Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic, Rybelsus) and chronic weight management (Wegovy)
The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
PlexusDx also offers GLP-Squared, a dual compound designed to enhance peptide efficacy through carefully balanced formulations (ranging $289/mo month-to-month, or from $249/mo on the 3-month plan) and the innovative Microdose GLP-1 Protocol ($129/month) for patients seeking lower-dose entry points or those with heightened sensitivity to standard dosing
Supporting healthy nervous, respiratory, and gastrointestinal systems*
The use of garcinia extract (hydroxycitric acid) as a weight loss supplement: A systematic review and meta-analysis of randomised clinical trials
Every entry introduces microscopic amounts of air and potential contaminants
US$ 27.18
US$ 28.92
US$ 28.07
US$ 26.03
US$ 28.89
